DISHMAN CARBOGEN AMCIS
Quarterly Results Analysis [Mar2025]
DISHMAN CARBOGEN AMCIS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹716 Cr | ₹682 Cr | ₹789 Cr | ₹524 Cr | ₹655 Cr | ₹651 Cr | ₹587 Cr | ₹723 Cr |
Expenses | ₹564 Cr | ₹542 Cr | ₹642 Cr | ₹495 Cr | ₹592 Cr | ₹610 Cr | ₹526 Cr | ₹602 Cr |
Operating Income | ₹153 Cr | ₹140 Cr | ₹147 Cr | ₹29 Cr | ₹63 Cr | ₹41 Cr | ₹61 Cr | ₹122 Cr |
Other Income | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹1 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹7 Cr |
Interest | ₹42 Cr | ₹49 Cr | ₹37 Cr | ₹32 Cr | ₹31 Cr | ₹33 Cr | ₹27 Cr | ₹28 Cr |
Depreciation | ₹79 Cr | ₹72 Cr | ₹72 Cr | ₹71 Cr | ₹85 Cr | ₹80 Cr | ₹75 Cr | ₹70 Cr |
Profit Before Tax | ₹28 Cr | ₹27 Cr | ₹42 Cr | ₹-78 Cr | ₹-49 Cr | ₹-66 Cr | ₹-36 Cr | ₹29 Cr |
Profit After Tax | ₹43 Cr | ₹5 Cr | ₹33 Cr | ₹-78 Cr | ₹-70 Cr | ₹-60 Cr | ₹-41 Cr | ₹17 Cr |
EPS | ₹2.75 | ₹0.30 | ₹2.11 | ₹-4.95 | ₹-4.46 | ₹-3.80 | ₹-2.61 | ₹1.08 |
Industry Peers & Returns | 1W | 1M | 1Y |
DISHMAN CARBOGEN AMCIS | 3.4% | -6.2% | 42.5% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | 0.6% | 9.5% |
DIVIS LABORATORIES | 3.7% | 5.1% | 49.1% |
CIPLA | -1% | 1.7% | 2.4% |
TORRENT PHARMACEUTICALS | 3.8% | 6.8% | 22.5% |
DR REDDYS LABORATORIES | -3.7% | 1.9% | -0.3% |
MANKIND PHARMA | 3.6% | 1.5% | 7.5% |
ZYDUS LIFESCIENCES | 1.4% | 7.5% | -6.8% |
LUPIN | 2.2% | 0.7% | 21% |
DISHMAN CARBOGEN AMCIS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.98 % |
Y-o-Y | 9.41 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹716 Cr | 4.98 | |
Dec2024 | ₹682 Cr | -13.52 | |
Sep2024 | ₹789 Cr | 50.64 | |
Jun2024 | ₹524 Cr | -20.00 | |
Mar2024 | ₹655 Cr | 0.56 | |
Dec2023 | ₹651 Cr | 11.00 | |
Sep2023 | ₹587 Cr | -18.91 | |
Jun2023 | ₹723 Cr | - |
DISHMAN CARBOGEN AMCIS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 8.96 % |
Y-o-Y | 143.60 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹153 Cr | 8.96 | |
Dec2024 | ₹140 Cr | -4.77 | |
Sep2024 | ₹147 Cr | 407.94 | |
Jun2024 | ₹29 Cr | -53.78 | |
Mar2024 | ₹63 Cr | 52.47 | |
Dec2023 | ₹41 Cr | -32.44 | |
Sep2023 | ₹61 Cr | -50.07 | |
Jun2023 | ₹122 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 3.80 % |
Y-o-Y | 122.78 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 21.32% | 3.80 | |
Dec2024 | 20.54% | 10.13 | |
Sep2024 | 18.65% | 237.25 | |
Jun2024 | 5.53% | -42.22 | |
Mar2024 | 9.57% | 51.66 | |
Dec2023 | 6.31% | -39.15 | |
Sep2023 | 10.37% | -38.46 | |
Jun2023 | 16.85% | - |
DISHMAN CARBOGEN AMCIS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 830.67 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹43 Cr | 830.67 | |
Dec2024 | ₹5 Cr | -86.01 | |
Sep2024 | ₹33 Cr | Positive | |
Jun2024 | ₹-78 Cr | Negative | |
Mar2024 | ₹-70 Cr | Negative | |
Dec2023 | ₹-60 Cr | Negative | |
Sep2023 | ₹-41 Cr | Negative | |
Jun2023 | ₹17 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 785.29 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.02 % | 785.29 | |
Dec2024 | 0.68 % | -83.77 | |
Sep2024 | 4.19 % | Positive | |
Jun2024 | -14.81 % | Negative | |
Mar2024 | -10.68 % | Negative | |
Dec2023 | -9.16 % | Negative | |
Sep2023 | -6.97 % | Negative | |
Jun2023 | 2.35 % | - |
DISHMAN CARBOGEN AMCIS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 816.67 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.75 | 816.67 | |
Dec2024 | ₹0.3 | -85.78 | |
Sep2024 | ₹2.11 | Positive | |
Jun2024 | ₹-4.95 | Negative | |
Mar2024 | ₹-4.46 | Negative | |
Dec2023 | ₹-3.8 | Negative | |
Sep2023 | ₹-2.61 | Negative | |
Jun2023 | ₹1.08 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD